Drug/Device and Device/Drug combinations in the EU and USA

12-Feb-2015

21 - 22 April 2015, Conference, The Rembrandt Hotel, London, UK

21 - 22 April 2015

Conference

The Rembrandt Hotel, London, UK


Practical guidance on borderline issues and combination products.

Organiser: Management Forum

Related Content

Variations to Marketing Authorisations in the EU
Variations to Marketing Authorisations in the EU
Advanced Pharmacovigilance
Advanced Pharmacovigilance
Keeping Up-To-Date as a (GMP) Qualified Person
Keeping Up-To-Date as a (GMP) Qualified Person
Pharmaceutical Regulatory Affairs in the Middle East
Pharmaceutical Regulatory Affairs in the Middle East
Biotechnology for the Non-Biotechnologist
Biotechnology for the Non-Biotechnologist
Injectable Drug Delivery
Injectable Drug Delivery
Nasal Drug Delivery
Nasal Drug Delivery
Essential GCP ICH E6 R2 Update
Essential GCP ICH E6 R2 Update
Pharmacovigilance
Pharmacovigilance
Clinical Trial Regulatory Guideline Requirements
Clinical Trial Regulatory Guideline Requirements
The New Saudi Arabian Pharmacovigilance Guidelines of June 2015, Dubai
The New Saudi Arabian Pharmacovigilance Guidelines of June 2015, Dubai
Medical Device Studies: Clinical Evidence
Medical Device Studies: Clinical Evidence
Pharmaceutical Regulatory Affairs in the Middle East, Dubai
Pharmaceutical Regulatory Affairs in the Middle East, Dubai
Pharmaceutical Regulatory Affairs in Africa
Pharmaceutical Regulatory Affairs in Africa
Regulatory Affairs for Support Staff
Regulatory Affairs for Support Staff